Terms: = Lung cancer AND TOP2A, TOP2, TP2A AND Staging
5 results:
1. Automated mapping and N-staging of thoracic lymph nodes in contrast-enhanced CT scans of the chest using a fully convolutional neural network.
Iuga AI; Lossau T; Caldeira LL; Rinneburger M; Lennartz S; Große Hokamp N; Püsken M; Carolus H; Maintz D; Klinder T; Persigehl T
Eur J Radiol; 2021 Jun; 139():109718. PubMed ID: 33962109
[TBL] [Abstract] [Full Text] [Related]
2. Comparative evaluation of three proliferation markers, Ki-67, top2a, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
[TBL] [Abstract] [Full Text] [Related]
3. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract] [Full Text] [Related]
4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract] [Full Text] [Related]
5. Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer.
Han Y; Yu DP; Zhou SJ; Song XY; Li YS; Xiao N; Liu ZD; Sun XJ; Zhao QY; Liu SK
Genet Mol Res; 2014 Oct; 13(4):8913-24. PubMed ID: 25366782
[TBL] [Abstract] [Full Text] [Related]
